Gut dysbiosis impacts the immune system and promotes prostate cancer
Immunology Letters · 2024-08 · 268 · 106883
DOI: 10.1016/j.imlet.2024.106883 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology Letters, 2024-08. Verfasst von Ritis K Shyanti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, AL 36104, USA. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Prostatic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
The gut microbiota is a system of microorganisms in the human gastrointestinal (GI) system, consisting of trillions of microorganisms residing in epithelial surfaces of the body. Gut microbiota are exposed to various external and internal factors and form a unique gut-associated immunity maintained through a balancing act among diverse groups of microorganisms. The role of microbiota in dysbiosis of the gut in aiding prostate cancer development has created an urgency for extending research toward comprehension and preventative measures. The gut microbiota varies among persons based on diet, race, genetic background, and geographic location. Bacteriome, mainly, has been linked to GI complications, metabolism, weight gain, and high blood sugar. Studies have shown that manipulating the microbiome (bacteriome, virome, and mycobiome) through the dietary intake of phytochemicals positively influences physical and emotional health, preventing and delaying diseases caused by microbiota. In this review, we discuss the wealth of knowledge about the GI tract and factors associated with dysbiosis-mediated compromised gut immunity. This review also focuses on the relationship of dysbiosis to prostate cancer, the impact of microbial metabolites short-chain fatty acids (SCFAs) on host health, and the phytochemicals improving health while inhibiting prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, AL 36104, USA.
- Department of Zoology, University of Lucknow, Lucknow, Uttar Pradesh 226007, India.
- Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, AL 36104, USA. Electronic address: mmishra@alasu.edu.
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- American Cancer Society
- National Institutes of Health
Zitieren
APA
Shyanti, R. K., Greggs, J., Malik, S., & Mishra, M. (2024). Gut dysbiosis impacts the immune system and promotes prostate cancer. Immunology Letters, 268, 106883. https://doi.org/10.1016/j.imlet.2024.106883
Vancouver
Shyanti RK, Greggs J, Malik S, Mishra M. Gut dysbiosis impacts the immune system and promotes prostate cancer. Immunology Letters. 2024;268:106883. doi:10.1016/j.imlet.2024.106883
BibTeX
@article{Shyanti2024,
author = {Shyanti, Ritis K and Greggs, Jazmyn and Malik, Shalie and Mishra, Manoj},
title = {Gut dysbiosis impacts the immune system and promotes prostate cancer},
journal = {Immunology Letters},
year = {2024},
volume = {268},
pages = {106883},
doi = {10.1016/j.imlet.2024.106883}
}
EUVIMED